Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Cancer Cell|June 11, 2024
Finding the sweet spot: Targeting RAS in tumors while sparing normal tissueNaiara Perurena, Karen CichowskiNature Reviews. Cancer|April 16, 2024
Combinatorial strategies to target RAS-driven cancersNaiara Perurena, Lisa Situ, Karen CichowskiAmerican Journal of Respiratory and Critical Care Medicine|July 2, 2015
Bone metastases in lung cancer. Potential novel approaches to therapySilvestre Vicent, Naiara Perurena, Ramaswamy Govindan, et al.Cancer Research|March 20, 2023
DAB2IP Is a Bifunctional Tumor Suppressor That Regulates Wild-Type RAS and Inflammatory Cascades in KRAS Mutant Colon CancerAbigail L Miller, Naiara Perurena, Alycia Gardner, et al.Journal of Hematology & Oncology|January 21, 2017
EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growthNaiara Perurena, Carolina Zandueta, Susana Martínez-Canarias, et al.Cancer Research|January 6, 2026
EZH2 Inhibitors Sensitize Breast Cancer to HER2 Kinase Inhibitors through Cooperative Effects on YAP and Pro-apoptotic RegulatorsNaiara Perurena, Marina Watanabe, Amy E Schade, et al.The Journal of Pathology|May 13, 2016
Matrix-Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosisCarolina Zandueta, Cristina Ormazábal, Naiara Perurena, et al.The Journal of Clinical Investigation|June 29, 2023
Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancerFrancesca Nardi, Naiara Perurena, Amy E Schade, et al.American Journal of Respiratory and Critical Care Medicine|January 13, 2018
Blockade of the Complement C5a/C5aR1 Axis Impairs Lung Cancer Bone Metastasis by CXCL16-mediated EffectsDaniel Ajona, Carolina Zandueta, Leticia Corrales, et al.American Journal of Respiratory and Critical Care Medicine|March 31, 2012
Receptor of activated protein C promotes metastasis and correlates with clinical outcome in lung adenocarcinomaIker Antón, Eva Molina, Diego Luis-Ravelo, et al.Pageof 2